Gastrointestinal disease control after histamine2-receptor antagonist dose modification for renal impairment in frail chronically ill elderly patients.

Objectives: To determine whether histamine2-receptor antagonist (H2RA) dose modified for renal impairment affects gastrointestinal (GI) disease control.

Design: Concurrent medical record review.

Setting: One hundred forty-six nursing facilities throughout the United States.